LIVER AKI: A Randomized, Open-label Trial to Evaluate the Efficacy of Intravenous Human Albumin Administration Versus Saline Solution in Patients With Decompensated Cirrhosis and AKI 1B or Grater.

• Status: NOT_YET_RECRUITING
• Trial end date: 2028-02-01

Summary

This is a phase IV, unicentric, open-label. Patients eligible for this study will be patients with AKI 1B or greater and decompensated cirrhosis from the hospital participating in the study

• Phase: PHASE4

Details

• Lead Sponsor: Fundacion Clinic per a la Recerca Biomdica
• Treatments: Saline Solution; Sodium Chloride